-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$255.8034.26% Upside
BeiGene, Ltd. Frequently Asked Questions
-
What analysts cover BeiGene, Ltd.?
BeiGene, Ltd. has been rated by research analysts at JMP Securities, Morgan Stanley, Jefferies, Bernstein, Guggenheim in the past 90 days.